Dec 22 2020 |
340b Update: Recent Supreme Court Ruling May Curtail 340b Program Discriminatory Pricing |
K&L Gates LLP |
Dec 22 2020 |
FDA Proposes to Revoke Standard of Identity for French Dressing |
Keller and Heckman LLP |
Dec 22 2020 |
FDA in 2020: What a Year! (Part 2 of 3) |
Mintz |
Dec 21 2020 |
An Early Holiday Present for Generics? Legislation Requiring Greater Disclosure by Brands Passes the Senate |
McDermott Will & Schulte LLP |
Dec 21 2020 |
Top Five Drug and Device Developments of 2020 |
Faegre Drinker |
Dec 21 2020 |
Restrictions on Venue in Hatch-Waxman Litigation |
Epstein Becker & Green, P.C. |
Dec 21 2020 |
Round Two - FDA Issues Emergency Use Authorization for Moderna’s COVID-19 Vaccine |
Foley & Lardner LLP |
Dec 21 2020 |
FDA Guidance: Use of “Potassium Salt” as an Alternate Name for “Potassium Chloride” in Food Labeling |
Keller and Heckman LLP |
Dec 21 2020 |
Election 2020 Putting Cannabis Center Stage |
Squire Patton Boggs (US) LLP |
Dec 21 2020 |
Launching a Drug or Medical Device in India: From Clinical Trial to Sale [PODCAST} |
Nishith Desai Associates |
Dec 19 2020 |
EPA Announces New Policy for Registrants Voluntarily to Disclose Inert Ingredients in Antimicrobial Products |
Bergeson & Campbell, P.C. |
Dec 18 2020 |
FDA Proposes Revocation of Frozen Cherry Pie Standards of Identity and Quality |
Keller and Heckman LLP |
Dec 18 2020 |
Introduction to the Pharma & Healthcare Podcast Series [PODCAST] |
Nishith Desai Associates |
Dec 17 2020 |
New Administration Could Provide Ideal Backdrop for Tribes Entering Cannabis Industry |
Van Ness Feldman LLP |
Dec 17 2020 |
FTC Cracks Down on Health Claims by CBD Companies |
Squire Patton Boggs (US) LLP |
Dec 17 2020 |
EEOC Updates COVID-19 Guidance on Employer Administered or Mandated Vaccinations |
Epstein Becker & Green, P.C. |
Dec 17 2020 |
“Bee Better Certified™ Seal” That Tells Consumers Certified Ingredients Are Grown in Ways That Support Bees Gains Traction |
Keller and Heckman LLP |
Dec 17 2020 |
FDA Issues New Guidance on Drug Naming |
Mintz |
Dec 16 2020 |
China Solicits Comments on Food-Contact Substances December 16, 2020 |
Keller and Heckman LLP |
Dec 16 2020 |
When Can Hospitals Be Subjected to Strict Product Liability? The Connecticut Supreme Court Is Mulling It Over. |
Wiggin and Dana LLP |
Dec 16 2020 |
Proposed Class Sues Cheese Producer Over Smokey Flavor Labeling |
Keller and Heckman LLP |
Dec 16 2020 |
Hemp Suits: Proactive Risk Management is Key |
Ward and Smith, P.A. |
Dec 15 2020 |
New York Bans PFAS in Food Packaging |
Keller and Heckman LLP |
Dec 15 2020 |
FDA in 2020: What a Year! |
Mintz |
Dec 15 2020 |
California Moves for Summary Judgment Against Mikoyo on Claims Related to Marketing of Plant-Based “Butter” |
Keller and Heckman LLP |
Dec 15 2020 |
Supreme Court Rules that ERISA Does Not Preempt State Law Regulating PBM Reimbursements |
Robinson & Cole LLP |
Dec 15 2020 |
HRSA Publishes Long-Awaited 340B Program Administrative Dispute Resolution Procedures |
Dinsmore & Shohl LLP |
Dec 15 2020 |
New HHS Board Will Hear 340B Drug Pricing Disputes |
Foley & Lardner LLP |
Dec 14 2020 |
Second Circuit Affirms Mirena MDL Court’s “Hard Look” at Plaintiffs’ Experts’ Methodology |
Faegre Drinker |
Dec 14 2020 |
U.S. Supreme Court: State Law Regulating Pharmacy Benefit Managers is Not Preempted by ERISA |
Jackson Lewis P.C. |
Dec 14 2020 |
USDA Will Prohibit the Statements “No Nitrate or Nitrite Added” and “Uncured” on Products That Have Been Processed Using Any Source of Nitrates or Nitrites |
Keller and Heckman LLP |
Dec 12 2020 |
COVID-19 Weekly Newsletter: FDA Committee Recommends Vaccine Approval |
Faegre Drinker |
Dec 11 2020 |
HRSA Publishes Long-Awaited (and Long-Overdue) 340 B Program Alternative Dispute Resolution Process Final Rule |
K&L Gates LLP |
Dec 11 2020 |
Pennsylvania’s COVID Christmas Closure 2020 |
Norris McLaughlin P.A. |
Dec 11 2020 |
Madison Takes ‘Pot’shot at Wisconsin, Joins Growing List of Municipalities to Decriminalize Cannabis |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |